Company / Profit Margin
RIGEL PHARMACEUTICALS INC Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
124.7%
FY2025
5-year range
-48.7% / 124.7%
FY2021-FY2025
Trend
+1179.2%
vs FY2024
Sector context
#2 of 145
Health Care
What the data says
Profit Margin changed +1179% YoY in FY2025, a notable deviation from the 7-year average annual change of +182%.
Based on SEC 10-K filings.
124.7% in FY2025 with a 5-year CAGR of +152.1%. Ranks 2nd among 145 companies in Health Care.
Improved from -21.5% to 124.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +173.4pp
- 5-Year Change
- +152.1pp
- 10-Year Change
- -
Sector benchmark
Top 1% in Health CareTop 1% of 145This company 124.7% Sector average -792.7%
▼
+115.7% above sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 1179.2% year-over-year.
- Currently 917.4pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 124.7% | +1179.2% |
| FY2024 | 9.8% | +145.4% |
| FY2023 | -21.5% | +55.9% |
| FY2022 | -48.7% | -305.9% |
| FY2021 | -12.0% | +56.2% |
| FY2020 | -27.4% | +75.7% |
| FY2019 | -112.8% | +66.8% |
| FY2018 | -339.6% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026